WTO IP Council: Praise For Public-Private Partnerships, Use Of Competition Law To Fight High Drug Prices 18/02/2019 by Catherine Saez, Intellectual Property Watch Leave a Comment At the World Trade Organization Council for Trade-Related Aspects of Intellectual Property Rights (TRIPS) – which met on 13 February and finished in one day – discussions on IP and innovation, and IP and the public interest delineated points of views but also provided concrete examples of successful use of public-private partnerships, and use of competition law to prevent excessive pricing.
WIPO Event: AI On All Fronts – Health, Cities, Agriculture – But Investment Needed; Europe Lagging 12/02/2019 by Catherine Saez, Intellectual Property Watch 1 Comment Artificial intelligence is with us to stay, and you can expect solutions to great challenges, but governments should be prepared to invest in education and research to keep up with the two global leaders of the field: the United States and China. This is in essence what several speakers said recently at an event held at the World Intellectual Property Organization.
IP Still At Heart Of Access To Medicines Discussions At WHO 07/02/2019 by Catherine Saez, Intellectual Property Watch Leave a Comment Intellectual property is often pointed at as hindering access to medicines by resulting in their long-lasting unaffordability, a view which is strongly opposed by IP proponents. The discussions on access to medicines last week during the World Health Organization Executive Board meeting yielded a record number of interventions by member states and nongovernmental organisations, reflecting the importance of the issue.
TRIPS Debated As WHO Board Reaches Agreement On Universal Health Coverage 05/02/2019 by Catherine Saez, Intellectual Property Watch Leave a Comment World Health Organization Board members agreed last week on a draft resolution for the preparation of a United Nations General Assembly high-level meeting on universal health coverage in the fall, following intensive closed consultations in which intellectual property rights played a significant role.
WHO Board Sceptical On Changes To Global Flu Framework, Sends Issue To WHA 04/02/2019 by Catherine Saez, Intellectual Property Watch 2 Comments The World Health Organization Executive Board last week remained uncertain on the way forward on questions of access to influenza viruses as countries are increasingly implementing an international protocol regulating the sharing of genetic resources. The Board requested informal discussions be held in the lead-up to the annual World Health Assembly in May.
WHO Governance Questioned As It Adds World Health Assembly Agenda Item On Biodiversity 01/02/2019 by Catherine Saez, Intellectual Property Watch 3 Comments The World Health Organization today admitted to an unusual procedure to set up a debate on the health implications of a UN treaty on sharing of benefits from genetic resources. The new agenda item proposed by the WHO director general was accepted by the WHO Board today, but with member states questioning the governance of the move.
Switzerland Receives Request For Compulsory Licence On Breast Cancer Drug 01/02/2019 by Intellectual Property Watch Leave a Comment Swiss health activist group Public Eye yesterday requested the Swiss government to declare a compulsory licence for a Roche breast cancer treatment which the group says is unaffordable.
WIPO Sheds Light On Artificial Intelligence Patenting Trends In New Report 31/01/2019 by Catherine Saez, Intellectual Property Watch Leave a Comment The World Intellectual Property Organization today released its first report on artificial intelligence showing a sharp rise in patenting activities over the last few years. WIPO Director General Francis Gurry called artificial intelligence a “game changer” during a press briefing yesterday and said WIPO hopes to spark a conversation on the issue among its member states this year. As in most other fields, leading patent offices are the United States and China.
Board Debates Medicines Access; WHO Asserts Mandate On IP, Trade Issues 30/01/2019 by Catherine Saez, Intellectual Property Watch Leave a Comment Shortages, faulty supply chains, unbearable prices, weak health systems – the issue of access to medicines is multifaceted and gave way to a long list of interventions yesterday at the World Health Organization. Challenged on its mandate to address intellectual property and trade issues, WHO Director General Tedros Adhanom Gheyebresus (Dr Tedros) confirmed that WHO’s mandate includes work with partners on those issues. Discussions also included fair pricing and transparency, for which Italy called for a resolution at the next World Health Assembly.
WHO Holds Discussions On Roadmap For Improving Access To Medicines 29/01/2019 by Catherine Saez, Intellectual Property Watch 2 Comments Unaffordable prices, unavailable medicines, a rising need for accessible noncommunicable diseases treatments – these set the stage as the World Health Organization Executive Board started discussion today on one of the more contentious issues of the week. For the Board’s approval is in particular a roadmap and action plan including a dual strategy based on safety and efficacy of health products, and their affordability.